Search by Drug Name or NDC
NDC 23155-0049-05 FELODIPINE 5 mg/1 Details
FELODIPINE 5 mg/1
FELODIPINE is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is FELODIPINE.
MedlinePlus Drug Summary
Felodipine is used to treat high blood pressure. Felodipine is in a class of medications called calcium channel blockers. It works by relaxing the blood vessels so your heart does not have to pump as hard. High blood pressure is a common condition and when not treated, can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 23155-0049-05Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Felodipine
Product Information
| NDC | 23155-0049 |
|---|---|
| Product ID | 23155-049_1fdb9a9f-baeb-46c0-91b8-6552c3784c39 |
| Associated GPIs | 34000013007510 |
| GCN Sequence Number | 016295 |
| GCN Sequence Number Description | felodipine TAB ER 24H 5 MG ORAL |
| HIC3 | A9A |
| HIC3 Description | CALCIUM CHANNEL BLOCKING AGENTS |
| GCN | 02621 |
| HICL Sequence Number | 006205 |
| HICL Sequence Number Description | FELODIPINE |
| Brand/Generic | Generic |
| Proprietary Name | FELODIPINE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | FELODIPINE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | FELODIPINE |
| Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA201964 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0049-05 (23155004905)
| NDC Package Code | 23155-049-05 |
|---|---|
| Billing NDC | 23155004905 |
| Package | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (23155-049-05) |
| Marketing Start Date | 2013-11-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |